To the Editor In a recent Viewpoint, Connor et al1 discussed diagnosis and risk classification in men with oligometastatic prostate cancer. They hypothesized that the diagnostic superiority of novel targeted imaging in detection of metastatic disease would allow early identification of oligometastatic prostate cancer, generating a stage migration and a so-called Will Rogers phenomenon for the survival of these patients.